| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 09/27/2007 | WO2007108936A2 N-substituted-azacyclylamines as histamine-3 antagonists |
| 09/27/2007 | WO2007108403A1 Quinoxaline derivative, and light-emitting element, light-emitting device, electronic device using the quinoxaline derivative |
| 09/27/2007 | WO2007107539A1 Compounds which potentiate ampa receptor and uses thereof in medicine |
| 09/27/2007 | WO2007107470A2 Pyrazoles as 11-beta-hsd-1 |
| 09/27/2007 | WO2007107298A1 Phthalazinone pyrazole derivatives, their manufacture and use as pharmaceutical agents |
| 09/27/2007 | WO2007089149A3 Water-soluble cc-1065 analogs and their conjugates |
| 09/27/2007 | WO2007085833A3 Pyrimidine derivatives |
| 09/27/2007 | US20070225495 N4-(2,2-Dimethyl-3-oxo-4H-5-pyrid[1,4]oxazin-6-yl)-N2-(3-chloro-4-methoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; signal transduction cascade inhibitor; Fc receptors for IgE (Fc epsilon RI) and IgG (Fc gamma RI) antagonist; autoimmune diseases, antiinflammatory agent; rheumatoid arthritis |
| 09/27/2007 | US20070225372 Amides as Bace Inhibitors |
| 09/27/2007 | US20070225352 methyl-[3-(2-nitro-phenylsulfanyl)-1-pyridin-2-ylmethyl-1H-indol-6-yl]-amine, possessing androgenic activity are useful in androgen-related treatments such as male hypogonadism, male and female hormone replacement therapy and male contraception |
| 09/27/2007 | US20070225344 Sulfonamide derivatives to treat infection with hepatitis C virus |
| 09/27/2007 | US20070225333 3-Heterocyclyl-4-Phenyl-Triazole Derivatives as Inhibitors of the Vasopressin Via Receptor |
| 09/27/2007 | US20070225321 2,4-pyrimidinediamine compounds and their uses |
| 09/27/2007 | US20070225307 C-met modulators and method of use |
| 09/27/2007 | US20070225297 Deuterated hepatitis C protease inhibitors |
| 09/27/2007 | US20070225296 Arylalkylamine Compound and Process for Preparing the Same |
| 09/27/2007 | US20070225294 2-[4-({[4-{[4-(4-acetylphenyl)-1-piperazinyl]methyl}-2-(4-fluorophenyl)-1,3-thiazol-5-yl]methyl}sulfanyl)-2-methylphenoxy]-2-methylpropanoic acid; dyslipidemia, syndrome X, hypercholesteremia, type II diabetes mellitus, type I diabetes, insulin resistance, hyperlipidemia, and obesity |
| 09/27/2007 | US20070225292 Therapeutic Compounds: Pyridine as Scaffold |
| 09/27/2007 | US20070225291 Substituted Pyrazinone Compounds for the Treatment of Inflammation |
| 09/27/2007 | US20070225287 Substituted Arylpyrazines |
| 09/27/2007 | US20070225286 Diseases with abnormal activation of the Abl, BCR-Abl, Bmx, CSK, TrkB, FGFR3, Fes, Lck, B-RAF, C-RAF, MKK6, alpha and beta SAPK2 kinases; antiproliferative; pyrrolo[2,3-d]pyrimidine-7-carboxylic acid [3-phenylcarbamoyl-phenyl]-amides and pyrrolo[3,2-c]pyridine analogs |
| 09/27/2007 | US20070225284 Inhibitors of soluble adenylate cyclase |
| 09/27/2007 | US20070225283 Conformationally restricted urea inhibitors of soluble epoxide hydrolase |
| 09/27/2007 | US20070225280 hydroxysteroid reductase inhibitors such as 2'-tert-butyl-2'H-[1,3']bipyrazolyl-4'-carboxylic acid (5-hydroxy-adamantan-2-yl)-amide, used for the treatment of non-insulin dependent diabetes mellitus and metabolic syndrome |
| 09/27/2007 | US20070225271 Pyrimidine, quinazoline, pteridine and triazine derivatives |
| 09/27/2007 | US20070225269 Use of (3-(1-(3-Phenyl-Propenyl)-Piperidin-4-Yl)-2,3-Dihydro-Indol-1-Yl)-(Pyridin-4-Yl)-Methanonone Derivatives and Related Compounds as Insecticides |
| 09/27/2007 | US20070222374 N,N',N'-triphenyl-N-[4-(3-phenylquinoxalin-2-yl)phenyl]benzene-1,4-diamine; bipolar, thermostability; light emiiting diodes with low driving voltage and low power consumption and high luminous efficiency |
| 09/27/2007 | CA2646585A1 Compounds which potentiate ampa receptor and uses thereof in medicine |
| 09/27/2007 | CA2646469A1 S1p receptor modulating compounds |
| 09/27/2007 | CA2646229A1 Deuterated hepatitis c protease inhibitors |
| 09/27/2007 | CA2645731A1 N-substituted-azacyclylamines as histamine-3 antagonists |
| 09/27/2007 | CA2645728A1 Phthalazinone pyrazole derivatives, their manufacture and use as pharmaceutical agents |
| 09/27/2007 | CA2645426A1 1-oxo-isoindoline compounds for the treatment of spinal muscular atrophy and other uses |
| 09/26/2007 | EP1837330A1 Benzamide inhibitors of the P2X7 receptor |
| 09/26/2007 | EP1836203A2 Heteroaryl substituted quinolin-4-ylamine analogues |
| 09/26/2007 | EP1836195A2 Preparation of crude candesartan cilexetil |
| 09/26/2007 | EP1836194A1 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their use in therapy |
| 09/26/2007 | EP1836191A1 Pyrazolylamino substituted quinazoles for the treatment of cancer |
| 09/26/2007 | EP1836188A1 Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases |
| 09/26/2007 | EP1836176A1 MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEROF |
| 09/26/2007 | EP1836166A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 09/26/2007 | EP1836163A2 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 09/26/2007 | EP1474416B1 Dihydrobenzodiazepin-2-one-derivatives for the treatment of neurological disorders |
| 09/26/2007 | EP1451153B1 Nk1 antagonists |
| 09/26/2007 | EP1406873B1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 09/26/2007 | EP1358181B1 Substituted pyrrolidines as ccr-3 receptor antagonists |
| 09/26/2007 | EP1339678B1 Ep4 receptor selective agonists in the treatment of osteoporosis |
| 09/26/2007 | EP1276732B1 Amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation" |
| 09/26/2007 | EP1263726B1 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor xa |
| 09/26/2007 | EP1261585B1 Substituted indole mannich bases |
| 09/26/2007 | CN101044137A 2,4-di(aminophenyl)pyrimidine derivatives as plk inhibitors |
| 09/26/2007 | CN101044136A Pyrrolo-naphthyl acids as pai-1 inhibitors |
| 09/26/2007 | CN101044123A Pyrimidine derivative fused with nonaromatic ring |
| 09/26/2007 | CN101044121A 4-aminopyrimidine-5-one |
| 09/26/2007 | CN101044114A Nitrobenzindoles and their use in cancer therapy |
| 09/26/2007 | CN101041669A Non nucleoside reverse transcriptase inhibitors |
| 09/26/2007 | CN101041638A Chirality amine containing imidazole sulfur ether structure and preparation method and usage thereof |
| 09/26/2007 | CN101041637A Chirality amine protonic acid salt containing imidazole sulfur ether structure and preparation method and usage thereof |
| 09/26/2007 | CN100339376C Nitrogen-containing aromatic ring derivatives |
| 09/26/2007 | CN100339352C 2-and 2,5-substituted phenylketoenols |
| 09/26/2007 | CN100339080C Antiviral compounds |
| 09/25/2007 | US7273939 Methods of making tris(N-aryl benzimidazoles)benzenes and their use in electronic devices |
| 09/25/2007 | US7273885 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 09/25/2007 | US7273868 excellent phosphodiesterase V (PDE V) inhibitory activity, and being useful as a remedy for the prophylaxis or treatment of penile erectile dysfunction with few side effects |
| 09/25/2007 | US7273862 Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives |
| 09/25/2007 | CA2376847C Complex of eletriptan and a cyclodextrin derivative |
| 09/25/2007 | CA2267928C Substituted 2-amino-4-alkylamino-1,3,5-triazines as herbicides |
| 09/25/2007 | CA2243317C Novel fused pyrrolecarboxamides; a new class of gaba brain receptor ligands |
| 09/25/2007 | CA2230199C Pyridazin-3-one derivatives, their use as a herbicide, and intermediates for their production |
| 09/20/2007 | WO2007106721A2 Cannabinoid receptor antagonists/inverse agonists useful for treating obesity |
| 09/20/2007 | WO2007106349A2 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues |
| 09/20/2007 | WO2007105753A1 Triazole derivative or salt thereof |
| 09/20/2007 | WO2007105058A2 Pyrazole compounds |
| 09/20/2007 | WO2007105053A2 Tetralines antagonists of the h-3 receptor |
| 09/20/2007 | WO2007105049A1 Dibenzyl amine derivatives as cetp inhibitors |
| 09/20/2007 | WO2007104560A1 Substituted 4-amino-quinazoline derivatives as regulators of metabotropic glutamate receptors and their use for producing drugs |
| 09/20/2007 | WO2007104538A1 Heterobicyclic carboxamides as inhibitors for kinases |
| 09/20/2007 | WO2007089768A3 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and pharmaceutical compositions containing them |
| 09/20/2007 | WO2007087518A3 2-substituted benzimidazoles as selective androgen receptor modulators (sarms) |
| 09/20/2007 | WO2007071396A8 Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions |
| 09/20/2007 | WO2006017384A3 Indazoles useful in treating cardiovascular diseases |
| 09/20/2007 | WO2002000649A9 Substituted quinazoline derivatives and their use as inhibitors |
| 09/20/2007 | US20070219240 N,N-Dimethyl-1-{4-[(2-phenyl-1H-benzimidazol-1-yl)methyl]-benzoyl}pyrrolidin-3-ylamine; cognition activator; neurodegenerative, developmental, sleep, eating disorders |
| 09/20/2007 | US20070219239 Nitrogen-containing heterocycle derivatives, pharmaceutical compositions, and methods of use thereof as antiviral agents |
| 09/20/2007 | US20070219235 Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors |
| 09/20/2007 | US20070219233 Substituted Indoles and Their Use as Integrin Antagonists |
| 09/20/2007 | US20070219218 Compounds for the treatment of inflammatory disorders |
| 09/20/2007 | US20070219217 Triazolone Derivatives as Mmp Inhibitors for the Treatment of Asthma and Copd |
| 09/20/2007 | US20070219211 Such as 6-[4-(5-Fluoro-2-trifluoromethylbenzoyl)piperazin-1-yl]imidazo[1,2-b]pyridazine-2-carboxylic acid (3-methylbutyl)amide; for diseases related to elevated lipid/cholesterol levels, cardiovascular disease, diabetes, obesity, and metabolic syndrome |
| 09/20/2007 | US20070219210 Amidopyrazole Derivative |
| 09/20/2007 | US20070219207 E.g. (2-isobutoxy-5-methanesulfonyl-phenyl)-(4-quinolin-2-yl-piperazin-1-yl)-methanone; glycine transporter 1 (GlyT-1) inhibitor, increasing activation of NMDA receptors; cognition activator; schizophrenia, psychoses, attention deficit disorders or Alzheimer's disease |
| 09/20/2007 | US20070219206 5-lipoxygenase-activating protein (flap) inhibitors |
| 09/20/2007 | US20070219202 3-(2-alkoxycarbonyl-3-indolyl)-3-oxo-propionic acid ester or propionamide intermediates: methyl 3-[6-fluoro-2-(methoxycarbonyl)-1-methyl-1H-indol-3-yl]-3-oxopropanoate; peripheral neuropathy, Parkinson's disease, Alzheimer's disease |
| 09/20/2007 | US20070219198 11b-hydroxysteroid dehydrogenase type 1 (11b-HSD1) for treatment of Type 2 diabetes, syndrome X, dyslipidemias, atherosclerosis, Alzheimer's and as wound healing agents; (2R)-1,1,1-trifluoro-2-[3-({(2R)-4-[4-fluoro-2-(trifluoromethyl)phenyl]-2-methylpiperazin-1-yl}sulfonyl)phenyl]propan-2-ol for example |
| 09/20/2007 | US20070219193 Alkylamine-substituted bicyclic aryl compounds useful as modulators of ppar |
| 09/20/2007 | US20070219182 1H-2-Benzazepine-1,5(2H)-dione derivatives in which the N is connected via alkylene to a saturated or monounsaterated nitrogen heterocycle, e.g.,2-(3-{4-[2-tert-Butyl-6-(trifluoromethyl)pyrimidin-4-yl]piperazin-1-yl}propyl)-3,4-dihydro-1H-2-benzazepine-1,5(2H)-dione; dopamine-3 receptor modulators |
| 09/20/2007 | US20070219140 Inhibitors of apoptosis proteins (IAP); antiproliferative agents; anticancer agents |
| 09/20/2007 | US20070218560 Isobaric sets, mass differential labeling sets; mass spectrometry |
| 09/20/2007 | US20070218136 New mandelic acid derivatives and their use as thrombin inhibitors |
| 09/20/2007 | CA2717242A1 Dibenzyl amine derivatives as cetp inhibitors |